Mumbai-based healthtech startup Rymo Technologies has raised ₹10 crore in a seed funding round, led by IAN Group through its evergreen fund, along with participation from angel investors.
The funding will support the company’s mission to make advanced neuro-rehabilitation more accessible and affordable through robotics, AI, and virtual reality.
Funding to Drive Innovation and Expansion
Rymo Technologies plans to use the newly raised capital to:
- Accelerate product innovation
- Expand manufacturing capabilities
- Strengthen presence across India
- Enter international markets such as ASEAN and the Middle East
This investment marks an important step in scaling its healthcare technology platform globally.
About Rymo Technologies
Founded in 2020 by Chirag Shah and Abhishek Rai, Rymo Technologies focuses on robotic neuro-rehabilitation solutions.
The company develops advanced systems that help patients recovering from:
- Stroke
- Neurological disorders
- Physical injuries
Its flagship product, Mobi-L system, is designed to improve mobility and independence through technology-driven therapy.
Solving a Critical Healthcare Gap
Rymo is addressing a major challenge in healthcare.
- Rising cases of stroke and neurological disorders globally
- Limited access to advanced rehabilitation facilities
- Shortage of trained therapists
- High cost of robotic therapy systems
By combining technology with affordability, the startup aims to bridge this gap in neuro-rehabilitation.
Technology and Product Innovation
Rymo Technologies has built a multi-layered technology platform that includes:
- Patented robotic hardware architecture
- AI-driven therapy personalization
- Proprietary algorithms trained on patient data
- Modular rehabilitation systems
Its multi-joint robotic systems are designed to deliver measurable recovery outcomes and improve therapy efficiency.
Strong Market Traction
The startup has already demonstrated significant adoption across the healthcare ecosystem.
Key Highlights:
- 452+ device installations
- 354 clinical customers
- Partnerships with leading institutions:
- AIIMS
- Apollo Hospitals
- Manipal Hospitals
- AIIMS
Impact on Patients
Rymo’s technology has already delivered meaningful outcomes:
- 7,500+ patients treated
- 15,000+ therapy hours delivered
- Up to 25% faster recovery outcomes (as per studies)
These results highlight the potential of AI-powered rehabilitation in improving patient care.
Growing Healthtech Opportunity
The global neuro-rehabilitation market is expanding rapidly due to:
- Aging population
- Increase in neurological conditions
- Demand for technology-driven healthcare solutions
Startups like Rymo are playing a key role in transforming traditional rehabilitation into data-driven, scalable healthcare systems.
Conclusion
With its ₹10 crore seed funding, Rymo Technologies is well-positioned to expand its AI-powered neuro-rehabilitation solutions across India and global markets.
By combining robotics, AI, and virtual reality, the company aims to make advanced rehabilitation accessible to more patients while improving recovery outcomes.
